Status:
UNKNOWN
Empowering Patients With Diabetes and Their Family Members: Assessing the Impact of Free Informative Mobile Messages
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This is a Randomized Control Trial aiming at investigating the feasibility and effectiveness of a WhatsApp-based informative intervention on Diabetes Mellitus care in Lebanon and exploring the impact ...
Detailed Description
Participants with diabetes will be equally and randomly divided into an intervention group (patients with diabetes and their designated family member) of individualized WhatsApp groups which will incl...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Participants with Diabetes:
- Adult patients 18 years or older
- Patients with an established DM diagnosis
- Patients with a recent HbA1c level with no recent changes in treatment regimen
- Recent HbA1c \> 7 but less than 9
- Patients who are on oral antidiabetic medications or basal insulin (intermediate, long acting, ultra long acting insulin)
- Patients who are adherents to the American University of Beirut Health Insurance Plan (AUB-HIP)
- Patients who have visited the Family Medicine Primary Care Clinics at American University of Beirut Clinics in the past 12 months.
- Patients with smart mobile phones and/or access to WhatsApp services
- Patients who can speak and read Arabic or English or live with someone who can read for them
- Patients with available family members involved in their care (e.g. cooking, aiding in management, securing/delivering medications, having the patient medically insured, etc.).
- Willingness to participate in the study
- Exclusion Criteria for participants with Diabetes:
- Young patients below 18 years
- Patients who are on non basal insulin/bolus therapy
- Adults with cognitive impairment
- Adults with functional dependence and no assisting family member or caregiver
- Pregnant and Postpartum patients
- Patients with terminal or critical diseases (e.g., cancer; advanced heart, lung, liver, and kidney disease; Human immunodeficiency virus infection and Acquired immune deficiency syndrome and etc.)
- Patients with severe hearing or visual impairment
- Patients who can't read or have difficulty reading and do not live with someone who can read for them
- Patients who will have any of their medications modified throughout the study process will be excluded from the study as well
- Patients with a positive depression (PHQ 2) and/or anxiety (GAD 2) screening results who will be asked to follow up with their primary physician
- Inclusion Criteria for Family Member Caregivers:
- Age 18 years or older
- Designated or selected by the participating patient with diabetes.
- Not diagnosed with DM
- Can read and write
- No visual or hearing impairments
- Involved in the participant's diabetes or general care and has an influence on the participant's lifestyle behaviors or medical insurance (e.g. cooking, aiding in management, securing/delivering medications, having the patient medically insured, etc.).
- Access to the WhatsApp service
- Willingness to participate in the study
Exclusion
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06176495
Start Date
January 1 2024
End Date
November 1 2024
Last Update
January 5 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.